IL6 and pachyonychia congenita: Collectively, these findings have provided convincing evidence suggesting that CDF could function as a novel anti-tumor agent, mediated through the deregulation of multiple signaling pathways including hypoxia-induced CSC phenotype and function within the tumor microenvironment, which contributes to the reduction of tumor aggressiveness of PC.